José Moreira
Professor
Translational and Clinical Pharmacology
Jagtvej 160
2100 København Ø
ORCID: 0000-0002-9944-1214
1 - 2 out of 2Page size: 10
- Published
Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer research
Celis, J. E., Gromov, P., Gromova, I., Moreira, J. M. A., Cabezón, T., Ambartsumian, N., Grigorian, M., Lukanidin, E., Thor Straten, P., Guldberg, P., Bartkova, J., Bartek, J., Lukas, J., Lukas, C., Lykkesfeldt, A., Jäättelä, M., Roepstorff, P., Bolund, L., Ørntoft, T. F., Brünner, N. & 5 others, , 2003, In: Molecular and Cellular Proteomics. 2, 6, p. 369-377 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses
Moreira, José, Scheipers, P. & Sørensen, P., 2003, In: B M C Cancer. 3, p. 30Research output: Contribution to journal › Journal article › Research › peer-review
ID: 37757167
Most downloads
-
1000
downloads
Comparative analysis of evolutionarily conserved motifs of epidermal growth factor receptor 2 (HER2) predicts novel potential therapeutic epitopes
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
367
downloads
FABP7 and HMGCS2 are novel protein markers for apocrine differentiation categorizing apocrine carcinoma of the breast
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
231
downloads
The stepwise evolution of the exome during acquisition of docetaxel resistance in breast cancer cells
Research output: Contribution to journal › Journal article › Research › peer-review
Published